Rx compliance study: no improvement found

16 July 2006

Prescription compliance by patients has not improved over the past three years, despite major educational efforts by health care providers and drug firms, according to research conducted by health care market research groups, Wilson Health Information and the J Scott Group, both Pennsylvania, USA-based.

A study of about 32,000 patients indicates that 35% did not complete their prescribed courses of medication, with "patient-perceived lack of need" the most frequent reason given (42%). Where patients did not follow directions but completed the treatment, "forgot to take" was the most common explanation (79%).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight